Sun Pharmaceutical Industries Financials Statements
Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios
Total Qtr Revenue cr | 16,099.38 | 14,948.23 | 14,315.86 | 13,571.71 | 14,141.08 |
| Other Income Qtr Cr | 578.84 | 469.92 | 464.46 | 612.87 | 465.62 |
| Operating Revenues Qtr | 15,520.54 | 14,478.31 | 13,851.40 | 12,958.84 | 13,675.46 |
Loading chart... | |||||
Operating Expenses Qtr | 10,572.05 | 9,951.26 | 9,549.74 | 9,242.75 | 9,666.44 |
Operating Profit Qtr | 4,948.49 | 4,527.05 | 4,301.66 | 3,716.09 | 4,009.02 |
EBITDA Qtr Cr | 5,359.42 | 4,996.97 | 3,948.12 | 3,967.28 | 4,158.47 |
Depreciation Qtr | 732.33 | 729.50 | 700.55 | 663.79 | 630.56 |
Net Profit Qtr | 3,368.81 | 3,117.95 | 2,278.63 | 2,149.88 | 2,903.38 |
Basic EPS Qtr | 14.00 | 13.00 | 9.50 | 9.00 | 12.10 |
Open Demat Account